US equities |
NVDA $238.30 ▲+1.86% SPCX $167.64 ▲+5.46% MU $1,063.05 ▼-1.10% TSLA $379.67 ▲+2.45% MSFT $525.08 ▲+1.46% SNDK $1,713.01 ▼-0.41% INTC $116.92 ▼-2.02% META $743.07 ▲+2.06%
FinancialContent

Articles published by Cidara Therapeutics, Inc.

News headline image
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2022
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX
News headline image
Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX
News headline image
Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S.
From Cidara Therapeutics, Inc.
Via GlobeNewswire
Tickers CDTX